Sevak Alaverdyan

6 ta ish

American University of Armenia

1. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

   Ruzilya Usmanova, Nargiza Parpieva, Hayk Davtyan +6

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

   ABIABI:AkademIndex/2026.other.262607

2. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018

   Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibos

   ABIABI:AkademIndex/2021.article.000692

3. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

   Laziz Turaev, Ajay Kumar, Dilyara Nabirova +3

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibos

   ABIABI:AkademIndex/2021.article.001408

4. Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +3

   MaqolaTuberculosis Research and Epidemiology20210 iqtibos

   ABIABI:AkademIndex/2021.article.002154

5. Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?

   Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +8

   MaqolaTuberculosis Research and Epidemiology20210 iqtibos

   ABIABI:AkademIndex/2021.article.010203

6. Role of ethnicity and residency in active tuberculosis in Karakalpakstan: study protocol of a matched case-control study

   Damin Asadov, Timur Aripov, Sevak Alaverdyan +4

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMJ Open Respiratory Research20240 iqtibos

   ABIABI:AkademIndex/2024.article.003805